Singapore markets closed
Straits Times Index
3,110.73 +36.47 (+1.19%) Nikkei
32,307.86 -550.45 (-1.68%) Hang Seng
16,334.37 -11.52 (-0.07%) FTSE 100
7,554.47 +40.75 (+0.54%) Bitcoin USD
43,748.06 -120.05 (-0.27%) CMC Crypto 200
914.81 +18.10 (+2.02%)
Seres Therapeutics, Inc. (MCRB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 140.89M |
| Enterprise value | 183.26M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | 1.09 |
| Price/book (mrq) | 63.84 |
| Enterprise value/revenue | 1.44 |
| Enterprise value/EBITDA | -1.48 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.49 |
| 52-week change 3 | -83.23% |
| S&P500 52-week change 3 | 15.38% |
| 52-week high 3 | 6.8700 |
| 52-week low 3 | 0.9100 |
| 50-day moving average 3 | 1.3739 |
| 200-day moving average 3 | 3.9328 |
Share statistics
| Avg vol (3-month) 3 | 3.54M |
| Avg vol (10-day) 3 | 2.27M |
| Shares outstanding 5 | 129.26M |
| Implied shares outstanding 6 | 129.26M |
| Float 8 | 97.49M |
| % held by insiders 1 | 6.68% |
| % held by institutions 1 | 81.36% |
| Shares short (14 Nov 2023) 4 | 23.37M |
| Short ratio (14 Nov 2023) 4 | 4.79 |
| Short % of float (14 Nov 2023) 4 | 34.00% |
| Short % of shares outstanding (14 Nov 2023) 4 | 18.08% |
| Shares short (prior month 12 Oct 2023) 4 | 22.85M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Sept 2023 |
Profitability
| Profit margin | -111.03% |
| Operating margin (ttm) | -15,294.52% |
Management effectiveness
| Return on assets (ttm) | -25.16% |
| Return on equity (ttm) | -538.57% |
Income statement
| Revenue (ttm) | 127.24M |
| Revenue per share (ttm) | 1.00 |
| Quarterly revenue growth (yoy) | -91.00% |
| Gross profit (ttm) | -165.79M |
| EBITDA | -130.53M |
| Net income avi to common (ttm) | -141.27M |
| Diluted EPS (ttm) | -1.1100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 169.91M |
| Total cash per share (mrq) | 1.32 |
| Total debt (mrq) | 212.28M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 2.71 |
| Book value per share (mrq) | -0.12 |
Cash flow statement
| Operating cash flow (ttm) | -122.75M |
| Levered free cash flow (ttm) | -91.02M |
© 2023 Yahoo. All rights reserved.